C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/14 (2006.01) A61K 31/4427 (2006.01) A61K 31/4545 (2006.01) C07D 211/58 (2006.01) C07D 401/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01)
Patent
CA 2501243
Disclosed are compounds of formula (I) wherein R1, R2, R3 and X are as defined herein, in free or salt form, which are useful as CCR5 inhibitors, e.g. in the prevention or treatment of disorders mediated by interactions between chemokine receptors and their ligands.
L'invention porte sur des composés de formule (I) (sous forme libre ou de sels), dans laquelle: R¿1?, R¿2?, R¿3? et X sont tels que définis dans la description, et utilisables comme inhibiteurs du CCR5, et notamment pour la prévention ou le traitement de troubles médiés par des interactions entre les récepteurs de la chémokine et leurs ligands.
Albert Rainer
Bruns Christian
Cooke Nigel Graham
Nuninger Francois
Streiff Markus
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Piperidine derivatives as ccr5 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives as ccr5 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives as ccr5 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1761107